Adagene Inc.
(NASDAQ: ADAG)
|
5:30 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $2.90 | Change: -0.09 | %Change: -3.01% | Volume: 5,291 |
Open: | $ 2.99 | Volume: | 5,291 | |
---|---|---|---|---|
High: | $ 3.05 | Yield(%) | 0.00 | |
Low: | $ 2.88 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 131.91M | |
EPS ($) | -0.84 | Shares Out: | 44.12M |
% Price Change (last 4 weeks): | 12.41 |
---|---|
% Price Change (last 13 weeks): | -0.33 |
% Price Change (last 26 weeks): | 52.55 |
% Price Change (last 52 weeks): | 103.40 |
% Price Change (year to date): | 54.81 |
Return on Equity (%): | -24.66 |
---|---|
Return on Assets (%): | -14.13 |
Return on Invested Capital (%): | -43.43 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | -104.61 |
Operating Profit Margin (%): | -150.18 |
|
|
50-day Moving Average: | $2.65 |
---|---|
200-day Moving Average: | $2.38 |
Avg. Daily Vol. (last 50 days): | 38,644 |
Avg. Daily Vol. (last 200 days): | 53,003 |
52-wk high: | $4.38 |
52-wk low: | $1.10 |
Bid: | $2.88 |
Ask: | $2.90 |
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
|
Adagene Inc.
Suzhou Industrial Park No. 218 Xingh Street 4/F, Building C14 Suzhou JS 215123 Phone: 86.512.8777.3632 Fax: 86.512.8777.3584 http://www.adagene.com |
Earnings (1year) ($): | -0.44 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 1.60 |
Cash Flow ($): | -0.40 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 4.67 |
Price/Book (x): | 1.21 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 3.61 |
---|---|
Current Ratio (x): | 3.61 |
LT Debt/Equity (x): | 19.44 |
Total Debt/Equity (x): | 31.61 |